1Department of Radiology, The First Medical Center, Chinese PLA General Hospital, Beijing, China
Presenting Author: Rui Hu
Synopsis
Motivation:
Goals:
Approach:
Results:
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
1. Yang J, Hong JC, Oh CW, et al. Clinicoepidemiological Features of Asymptomatic Moyamoya Disease in Adult Patients. Journal of Cerebrovascular and Endovascular Neurosurgery 2014;16. doi:10.7461/jcen.2014.16.3.241 [doi]
2. Karzmark P, Zeifert PD, Bell-Stephens TE, Steinberg GK, Dorfman LJ. Neurocognitive Impairment in Adults With Moyamoya Disease Without Stroke. Neurosurgery 2012;70:634-638. doi:10.1227/NEU.0b013e3182320d1a [doi]
3. He S, Duan R, Liu Z, et al. Characteristics of cognitive impairment in adult asymptomatic moyamoya disease. BMC neurology 2020;20:322. doi:10.1186/s12883-020-01898-8 [doi]
4. Musmar B, Roy JM, Abdalrazeq H, et al. Comparative Outcomes of Unilateral vs Bilateral Revascularization in Moyamoya Disease: A Multicenter Retrospective Study. Neurosurgery 2025;96:1364-1373. doi:10.1227/neu.0000000000003243 [doi]
5. Chen J-B, Liu Y, Zhou L-X, Sun H, He M, You C. Increased prevalence of autoimmune disease in patients with unilateral compared with bilateral moyamoya disease. Journal of Neurosurgery 2016;124:1215-1220. doi:10.3171/2015.4.JNS142936 [doi]